Get the Stockscreener App
176.42
9.62%
15.48
After Hours:
176.42
Iqvia Holdings Inc stock is traded at $176.42, with a volume of 4.14M.
It is up +9.62% in the last 24 hours and up +1.82% over the past month.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
See More
Previous Close:
$160.94
Open:
$159.8
24h Volume:
4.14M
Relative Volume:
1.91
Market Cap:
$29.61B
Revenue:
$16.30B
Net Income/Loss:
$1.36B
P/E Ratio:
22.45
EPS:
7.8573
Net Cash Flow:
$2.05B
1W Performance:
+10.97%
1M Performance:
+1.82%
6M Performance:
-16.04%
1Y Performance:
+15.84%
1-Day Range:
$156.62
$176.99
1-Week Range:
$154.50
$176.99
52-Week Range:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
176.42 | 27.02B | 16.30B | 1.36B | 2.05B | 7.8573 |
TMO
Thermo Fisher Scientific Inc
|
466.76 | 171.91B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.63 | 123.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.97 | 44.73B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
342.75 | 29.63B | 3.17B | 642.63M | 516.49M | 10.77 |
A
Agilent Technologies Inc
|
117.53 | 31.70B | 7.07B | 1.29B | 993.00M | 4.5355 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Mar-06-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQVIA jumps 9.6% as Q1 results top expectations and full-year EPS outlook rises - Quiver Quantitative
IQVIA Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
IQVIA (NYSE: IQV) grows Q1 2026 revenue to $4.15B and boosts EPS - Stock Titan
IQVIA signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue - MSN
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA Holdings Inc Stock (IQV) Closed Up by 9.60% on May 5: Key Drivers Unveiled - TradingKey
IQV Q1 Earnings Beat on Commercial Solutions Strength - TradingView
IQVIA Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
IQVIA Q1 2026 slides: revenue climbs 8.4%, guidance raised - Investing.com
IQVIA Reports First-Quarter 2026 Results - BioSpace
Earnings call transcript: IQVIA Holdings Q1 2026 beats forecasts, stock dips - Investing.com
IQVIA (IQV) Q1 2026 Earnings Call Transcript - The Globe and Mail
IQVIA lifts annual profit forecast as pharma spending improves - marketscreener.com
IQVIA Holdings Releases Q1 2026 Financial Results - AlphaStreet
IQVIA shares drop as book-to-bill ratio misses expectations By Investing.com - Investing.com Canada
IQVIA shares drop as book-to-bill ratio misses expectations - Investing.com
IQVIA Q1 Adjusted Earnings, Revenue Rise; Raises 2026 Adjusted Earnings Guidance - marketscreener.com
IQVIA (NYSE:IQV) Beats Q1 Estimates and Raises Guidance Despite Pre-Market Dip - ChartMill
IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
IQVIA’s (NYSE:IQV) Q1 CY2026 Sales Top Estimates - Yahoo Finance
(IQV) IQVIA Holdings Expects 2026 Revenue Range $17.15B$17.35B, vs. FactSet Est of $17.24B - marketscreener.com
IQVIA HOLDINGS ($IQV) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (IQV) IQVIA Holdings Inc. Reports Q1 Revenue $4.15B, vs. FactSet Est of $4.10B - marketscreener.com
Agentic AI in Clinical Development Market Is Going to Boom | IQVIA - openPR.com
IQVIA: Q1 Earnings Snapshot - Citizen Tribune
IQVIA Reports Q1 2026: Revenue $4.15B, Adjusted EBITDA $932M, Adj. Diluted EPS $2.90 - TradingView
Earnings Flash (IQV) IQVIA Holdings Inc. Posts Q1 Adjusted EPS $2.90 per Share, Vs. FactSet Est of $2.82 - Moomoo
IQVIA (IQV) posts Q1 2026 growth, strong cash flow and lifts EPS outlook - Stock Titan
IQVIA Q1 2026 earnings preview - MSN
MSN Money - MSN
IQVIA Set to Report Q1 Earnings: Here's What You Should Know - Yahoo Finance
IQVIA (IQV) Reports Earnings Tomorrow: What To Expect - Yahoo Finance UK
IQVIA earnings up next: Can pharma strength offset AI concerns? By Investing.com - Investing.com South Africa
IQVIA earnings up next: Can pharma strength offset AI concerns? - Investing.com
DUMONT & BLAKE INVESTMENT ADVISORS LLC's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Strs Ohio Sells 35,193 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Kornitzer Capital Management Inc. KS Sells 15,696 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
A Look At IQVIA Holdings' (IQV) Valuation After Its US$3.14b ESOP Shelf Registration Filing - Sahm
Here's why you should retain IQV stock in your portfolio now - MSN
JPMorgan Mid Cap Value Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
Artemis Investment Management LLP Takes Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com Nigeria
IQVIA Holdings earnings preview: What to expect - MSN
BMO Capital Adjusts Price Target on IQVIA Holdings to $210 From $250 - marketscreener.com
BMO cuts IQVIA stock price target on pharma backdrop expectations By Investing.com - Investing.com Canada
Vanguard reports 7.49% stake in IQVIA (NYSE: IQV) - Stock Titan
Earnings Preview: IQV to Report Financial Results Pre-market on May 05 - Moomoo
IQVIA Holdings Stock (US46266C1053): Scheduled to Report Q1 2026 Earnings - AD HOC NEWS
M&T Bank Corp Has $1.37 Million Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is It Time To Revisit IQVIA (IQV) After Its Sharp Year To Date Share Price Drop - simplywall.st
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.26%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):